Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.
about
Designing Safer Analgesics via μ-Opioid Receptor Pathways.Efficacy and safety of selective glucocorticoid receptor modulators in comparison to glucocorticoids in arthritis, a systematic review.Population Pharmacokinetics of Fosdagrocorat (PF-04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis.In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF-00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid Receptor.Mechanisms of NF-κB p65 and strategies for therapeutic manipulation
P2860
Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Improved disease activity with ...... s: a Phase 2 randomized study.
@ast
Improved disease activity with ...... s: a Phase 2 randomized study.
@en
Improved disease activity with ...... s: a Phase 2 randomized study.
@nl
type
label
Improved disease activity with ...... s: a Phase 2 randomized study.
@ast
Improved disease activity with ...... s: a Phase 2 randomized study.
@en
Improved disease activity with ...... s: a Phase 2 randomized study.
@nl
prefLabel
Improved disease activity with ...... s: a Phase 2 randomized study.
@ast
Improved disease activity with ...... s: a Phase 2 randomized study.
@en
Improved disease activity with ...... s: a Phase 2 randomized study.
@nl
P2093
P2860
P356
P1476
Improved disease activity with ...... s: a Phase 2 randomized study.
@en
P2093
Arnab Mukherjee
Charles Mebus
Dona Fleishaker
Thomas Stock
P2860
P356
10.1111/1756-185X.13053
P577
2017-03-22T00:00:00Z